Ask Questions About Clinical Trials

NCT07343297 | Not Yet Recruiting

• 1 other identifier: 2025-082
• Study Type: interventional
• Target: 293
• Locations: 0 countries
• Sites: N/A

Brief Summary

The overall goal of this study is to assess the implementation of the Ask Questions about Clinical Trials (ASQ-CT) brochure, a patient-focused communication tool previously demonstrated to improve patient-provider communication about clinical trials. Participants will be given the ASQ-CT brochure at Time 1 (baseline) and participants will complete a questionnaire at three timepoints, baseline (Time 1), Pre-Research Visit (Time 2), and Post-Research Visit (Time 3).

Conditions

Oncology; Cardiac Disease; Neurologic Disorder

Outcome Measures

Primary Outcomes (1)

• Effectiveness - Self-Efficacy in managing patient-provider interactions - Quantitative Scale

  Improvement of self-efficacy in managing patient-providers interactions between baseline (Time 1) and pre-clinic visit (Time 2). Measured using scale of 1-5 where a higher score is equal to a better outcome

  From Baseline (Time 1) to end of Pre-Clinic Visit (Time 2)

Secondary Outcomes (10)

• Reach - Number and Proportion

  At start of Participation

• Effectiveness - Self-Efficacy in managing patient-provider interactions - Quantitative Scale

  From Pre-Clinic (Time 2) to end of Post-Clinic Visit (Time 3) up to 3 months.

• Effectiveness - Knowledge - Quantitative Scale

  From Baseline (Time 1) to end of Pre-Clinic Visit (Time 2)

• Effectiveness - Knowledge - Quantitative Scale

  From Pre-Clinic Visit (Time 2) to end of Post-Clinic Visit (Time 3) up to 3 months

• Effectiveness - Trust - Quantitative Scale

  From Baseline (Time 1) to end of Pre-Clinic Visit (Time 2)

Study Arms (1)

Ask Questions about Clinical Trials (ASQ-CT) Brochure

EXPERIMENTAL

Ask Questions about Clinical Trials (ASQ-CT), a clinical trial communication intervention brochure

Behavioral: Ask Questions about Clinical Trials brochure

Interventions

Ask Questions about Clinical Trials brochure BEHAVIORAL

Communication intervention called a question prompt list

Ask Questions about Clinical Trials (ASQ-CT) Brochure

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Age \> or equal to 18 years
• Appointment to see a provider at a Karmanos Cancer Institute-McLaren or a medical encounter at McLaren Center for Research and Innovation (MCRI) site for medical/systemic treatment
• Potentially eligible for a clinical trial
• Speak and read English well enough to be able to understand consent documents and complete surveys

You may not qualify if:

• Not able to complete study documents on their own physically or cognitively

Sponsors & Collaborators

• Barbara Ann Karmanos Cancer Institute: lead

MeSH Terms

Conditions

Neoplasms; Heart Diseases; Nervous System Diseases

Condition Hierarchy (Ancestors)

Cardiovascular Diseases

Study Officials

• Lauren M Hamel, PhD, MBA

  Wayne State University

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Lauren M Hamel, PhD, MBA

CONTACT

1-800-527-6266; Lauren.Hamel@med.wayne.edu

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: December 15, 2025
• First Posted: January 15, 2026
• Study Start: April 30, 2026
• Primary Completion (Estimated): December 30, 2026
• Study Completion (Estimated): April 5, 2027
• Last Updated: January 15, 2026

Record last verified: 2026-01